<DOC>
	<DOC>NCT01688193</DOC>
	<brief_summary>The purpose of this study is to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male</brief_summary>
	<brief_title>Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male</brief_title>
	<detailed_description />
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<criteria>BMI: 18.0 27.0 kg/m2 Willingness to sign the written Informed Consent Form Evidence of clinically relevant pathology History of relevant drug and food allergies Positive screen on drugs of abuse Participation in a drug study within 60 days prior to drug administration.</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>